An Open Label Study to Investigate the Safety and Tolerability of Trichostatin A in Patients With Mild to Severe Onychomycosis
Latest Information Update: 28 Jul 2025
At a glance
- Drugs Trichostatin A (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors Vanda Pharmaceuticals
Most Recent Events
- 28 Jul 2025 New trial record